Product image of Lipistad (Atorvastatin) supplied by GNH India

Lipistad

Active Ingredient:
Atorvastatin
Origin:
EU

Lipistad (Atorvastatin)

Atorvastatin, the active ingredient in Lipistad, is a HMG‑CoA reductase inhibitor presented as an oral tablet for systemic use. It lowers elevated cholesterol and triglyceride levels and is prescribed for adults with primary or secondary lipid disorders to reduce cardiovascular risk.

GNH India supplies Lipistad as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution. Customers benefit from consistent product availability and regulatory support across multiple markets.

Manufacturer / TM Owner

Stada Arzneimittel Ag

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Atorvastatin is indicated for disorders of lipid metabolism and for cardiovascular risk reduction.

  • Hypercholesterolemia: reduces low‑density lipoprotein (LDL) cholesterol to target levels.
  • Mixed dyslipidemia: lowers LDL cholesterol while modestly raising high‑density lipoprotein (HDL) and reducing triglycerides.
  • Primary prevention of cardiovascular disease: decreases the incidence of myocardial infarction, stroke and related events in at‑risk patients.
  • Secondary prevention of cardiovascular disease: limits recurrent events in patients with established coronary artery disease or stroke.

How It Works

  • Atorvastatin competitively inhibits HMG‑CoA reductase, the key enzyme in hepatic cholesterol synthesis. This blockade reduces intracellular cholesterol, prompting up‑regulation of LDL receptors on hepatocyte surfaces, which accelerates clearance of circulating LDL particles. The net effect is a dose‑dependent decline in plasma LDL‑cholesterol, with modest reductions in triglycerides and modest increases in HDL‑cholesterol. By lowering hepatic cholesterol stores, the drug also diminishes VLDL production, further contributing to lipid profile improvement.

Side Effects

Atorvastatin may cause a range of adverse reactions, which are classified by frequency and severity.

Common Side Effects

  • Headache: mild to moderate pain in the head region.
  • Myalgia: muscle aches without weakness.
  • Gastrointestinal discomfort: nausea, abdominal pain or constipation.
  • Elevated liver enzymes: mild increase in ALT or AST.

Serious or Rare Side Effects

  • Rhabdomyolysis: severe muscle breakdown that can lead to kidney injury.
  • Acute liver injury: marked elevation of hepatic enzymes or hepatitis.
  • Allergic reactions: rash, pruritus, angioedema or anaphylaxis.

Precautions & Warnings

When prescribing Lipistad, clinicians should observe several safety considerations to minimize risk.

  • Pregnancy: contraindicated (Category X); avoid use in pregnant women.
  • Liver disease: assess hepatic function before initiation and monitor regularly.
  • Renal impairment: dose adjustment may be required in severe renal insufficiency.
  • Drug interactions: review concomitant medications that affect CYP3A4 metabolism.
  • Monitor lipid levels: periodic testing to evaluate therapeutic response.
  • Store at ambient temperature: keep below 25 °C in the original container, protected from moisture and light.

Avoid Interactions

Atorvastatin interacts with several medicines; some combinations require avoidance while others need careful monitoring.

Major Interactions (Avoid)

  • Strong CYP3A4 inhibitors (e.g., itraconazole, clarithromycin, ritonavir): can markedly increase atorvastatin exposure.
  • Gemfibrozil: synergistic risk of myopathy and rhabdomyolysis.
  • Colchicine: elevated risk of severe toxicity when combined.

Moderate Interactions (Monitor Closely)

  • Antacids containing aluminum or magnesium: may reduce atorvastatin absorption.
  • Warfarin: potential enhancement of anticoagulant effect, requiring INR monitoring.
  • Niacin: may increase risk of hepatotoxicity.

Frequently Asked Questions

Lipistad contains atorvastatin and is used to lower elevated cholesterol and triglyceride levels. It is prescribed for hypercholesterolemia, mixed dyslipidemia, and for both primary and secondary prevention of cardiovascular events such as heart attack and stroke in adult patients.

Atorvastatin blocks the enzyme HMG‑CoA reductase, which is essential for cholesterol synthesis in the liver. By inhibiting this step, the drug reduces intracellular cholesterol, leading to increased LDL‑receptor expression and enhanced removal of LDL particles from the bloodstream, thereby lowering plasma LDL‑cholesterol.

The dose of Lipistad is individualized by the prescribing clinician based on the patient’s lipid profile, cardiovascular risk, and tolerance. Physicians typically start with a low to moderate dose and may adjust upward to achieve target cholesterol levels, following current clinical guidelines.

Atorvastatin is classified as pregnancy category X, meaning it is contraindicated in pregnant women because of potential fetal harm. It is also not recommended for breastfeeding mothers, as it may pass into breast milk and affect the infant.

To order Lipistad, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Lipistad (atorvastatin) is a high‑potency statin that provides greater LDL‑cholesterol reductions at lower doses compared with older agents such as simvastatin. Its pharmacokinetic profile allows once‑daily dosing, and it has a well‑characterized safety record, though drug‑interaction potential must be managed.

Store Lipistad at ambient temperature, preferably below 25 °C, in the original packaging to protect it from moisture and light. Keep the container tightly closed and out of reach of children. Do not store in a bathroom or near a heat source.

Lipistad is taken orally, usually once daily, with or without food. The tablet should be swallowed whole with a full glass of water. Patients should follow the dosing schedule prescribed by their healthcare provider and not split or crush the tablet unless directed.

The most serious adverse events include rhabdomyolysis (severe muscle breakdown), acute liver injury, and severe allergic reactions such as anaphylaxis. Patients should report unexplained muscle pain, weakness, dark urine, jaundice, or signs of an allergic response to their clinician promptly.

Lipistad should not be used by individuals who are pregnant, nursing, or have known hypersensitivity to atorvastatin or any component of the formulation. It is also contraindicated in patients with active liver disease or unexplained persistent elevations of hepatic enzymes.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Atorvastatin

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT